Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

The Lancet Oncology

Volumn 18, Issue 3, 2017, Pages 336-346

  Erlandsson, Johan ^a   Holm, Torbjörn ^a   Pettersson, David ^b   Berglund, Åke ^c   Cedermark, Björn ^a   Radu, Calin ^c   Johansson, Hemming ^d   Machado, Mikael ^e   Hjern, Fredrik ^e   Hallböök, Olof ^f   Syk, Ingvar ^g   Glimelius, Bengt ^c   Martling, Anna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NORRTÄLJE HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e DANDERYD HOSPITAL   (Sweden)

^f LINKÖPING UNIVERSITY   (Sweden)

^g LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ACUTE RADIATION INDUCED TOXICITY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIARRHEA; DISTANT METASTASIS; FEMALE; FRACTIONATION; HOSPITALIZATION; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS ABSCESS; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RECURRENCE FREE SURVIVAL; REOPERATION; SURGICAL INFECTION; SURVIVAL RATE; SWEDEN; THERAPY DELAY; TIME TO TREATMENT; TOXICITY; TREATMENT DURATION; ADENOCARCINOMA; CANCER STAGING; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PREOPERATIVE CARE; PROGNOSIS; RADIATION DOSE FRACTIONATION; RECTAL NEOPLASMS; STANDARDS; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL RATE; TIME-TO-TREATMENT;

EID: 85012886071     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(17)30086-4     Document Type: Article

References (32)

1. 1 Frykholm, GJ, Glimelius, B, Pahlman, L, Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36 (1993), 564–572.
2. 2 Cedermark, B, Johansson, H, Rutqvist, LE, Wilking, N, The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 75 (1995), 2269–2275.
3. 3 Martling, A, Holm, T, Johansson, H, Rutqvist, LE, Cedermark, B, Stockholm Colorectal Cancer Study G. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 92 (2001), 896–902.
4. 4 Kapiteijn, E, Marijnen, CA, Nagtegaal, ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001), 638–646.
5. 5 Sebag-Montefiore, D, Stephens, RJ, Steele, R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373 (2009), 811–820.
6. 6 No authors listed. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336 (1997), 980–987.
7. 7 Glimelius, B, Optimal time intervals between pre-operative radiotherapy or chemoradiotherapy and surgery in rectal cancer?. Front Oncol, 4, 2014, 50.
8. 8 Pettersson, D, Cedermark, B, Holm, T, et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 97 (2010), 580–587.
9. 9 Pettersson, D, Lorinc, E, Holm, T, et al. Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg 102 (2015), 972–978.
10. 10 Pahlman, L, Bohe, M, Cedermark, B, et al. The Swedish rectal cancer registry. Br J Surg 94 (2007), 1285–1292.
11. 11 Cox, JD, Stetz, J, Pajak, TF, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995), 1341–1346.
12. 12 Rasanen, M, Carpelan-Holmstrom, M, Mustonen, H, Renkonen-Sinisalo, L, Lepisto, A, Pattern of rectal cancer recurrence after curative surgery. Int J Colorectal Dis 30 (2015), 775–785.
13. 13 Kodeda, K, Johansson, R, Zar, N, et al. Time trends, improvements and national auditing of rectal cancer management over an 18-year period. Colorectal Dis 17 (2015), O168–O179.
14. 14 Blomqvist, L, Glimelius, B, The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers. Acta Oncol 47 (2008), 5–8.
15. 15 Sauer, R, Becker, H, Hohenberger, W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004), 1731–1740.
16. 16 Pach, R, Kulig, J, Richter, P, Gach, T, Szura, M, Kowalska, T, Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer—treatment results at 5-year follow-up. Langenbecks Arch Surg 397 (2012), 801–807.
17. 17 Ngan, SY, Burmeister, B, Fisher, RJ, et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol 30 (2012), 3827–3833.
18. 18 Bosset, JF, Collette, L, Calais, G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006), 1114–1123.
19. 19 Braendengen, M, Tveit, KM, Berglund, A, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26 (2008), 3687–3694.
20. 20 Bujko, K, Nowacki, MP, Nasierowska-Guttmejer, A, Michalski, W, Bebenek, M, Kryj, M, Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006), 1215–1223.
21. 21 Petrelli, F, Sgroi, G, Sarti, E, Barni, S, Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: A Meta-analysis of Published Studies. Ann Surg 263 (2016), 458–464.
22. 22 Lefevre, JH, Mineur, L, Kotti, S, et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6). J Clin Oncol 34 (2016), 3773–3780.
23. 23 Hatfield, P, Hingorani, M, Radhakrishna, G, et al. Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol 92 (2009), 210–214.
24. 24 Pettersson, D, Holm, T, Iversen, H, Blomqvist, L, Glimelius, B, Martling, A, Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg 99 (2012), 577–583.
25. 25 Radu, C, Berglund, A, Pahlman, L, Glimelius, B, Short-course preoperative radiotherapy with delayed surgery in rectal cancer— a retrospective study. Radiother Oncol 87 (2008), 343–349.
26. 26 Veenhof, AA, Bloemena, E, Engel, AF, van der Peet, DL, Meijer, OW, Cuesta, MA, The relationship of histological tumor regression grade (TRG) and two different time intervals to surgery following radiation therapy for locally advanced rectal cancer. Int J Colorectal Dis 24 (2009), 1091–1096.
27. 27 Ansari, N, Solomon, MJ, Fisher, RJ, et al. Acute adverse events and postoperative complications in a randomized trial of preoperative short-course radiotherapy versus long-course chemoradiotherapy for T3 adenocarcinoma of the rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04). Ann Surg, 2016, 10.1097/sla.0000000000001987 published online Sept 14.
28. 28 Tevis, SE, Kohlnhofer, BM, Stringfield, S, et al. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Dis Colon Rectum 56 (2013), 1339–1348.
29. 29 Breugom, AJ, Swets, M, Bosset, JF, et al. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol 16 (2015), 200–207.
30. 30 Bujko, K, Glimelius, B, Valentini, V, Michalski, W, Spalek, M, Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: a meta-analysis of randomized trials comparing surgery +/− a fluoropyrimidine and surgery + a fluoropyrimidine +/- oxaliplatin. Eur J Surg Oncol 41 (2015), 713–723.
31. 32 Bujko, K, Wyrwicz, L, Rutkowski, A, et al. Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study. Ann Oncol 27 (2016), 834–842.
32. 31 Nilsson, PJ, van Etten, B, Hospers, GA, et al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer—the RAPIDO trial. BMC Cancer, 13, 2013, 279.